(Q34999297)

5 August 2017

title

Pharmacokinetic-pharmacodynamic modelling of the antihistaminic (H1) effect of bilastine (English)

1 reference

5 August 2017

1 reference

1 reference

Nerea Jauregizar

1

1 reference

5 August 2017

Leire de la Fuente

2

1 reference

5 August 2017

Maria Luisa Lucero

3

1 reference

5 August 2017

Ander Sologuren

4

1 reference

5 August 2017

Nerea Leal

5

1 reference

5 August 2017

Mónica Rodríguez

6

1 reference

5 August 2017

language of work or name

1 reference

1 January 2009

1 reference

Clinical Pharmacokinetics

5 August 2017

published in

1 reference

5 August 2017

volume

48

1 reference

5 August 2017

issue

8

1 reference

5 August 2017

page(s)

543-554

1 reference

Inhibition of histamine-induced skin wheal and flare after 5 days of mizolastine

5 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11317180-000000000-00000

Clinical pharmacology of new histamine H1 receptor antagonists

21 January 2018

1 reference

12 December 2020

Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models

1 reference

12 December 2020

A pharmacokinetic-pharmacodynamic modelling of the antihistaminic (H1) effects of cetirizine

1 reference

12 December 2020

Comparative activity of cetirizine and mizolastine on histamine-induced skin wheal and flare responses at 24 h.

1 reference

12 December 2020

Comparative wheal and flare study of mizolastine vs terfenadine, cetirizine, loratadine and placebo in healthy volunteers.

1 reference

12 December 2020

Mechanism-based pharmacodynamic modeling

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic modeling of mizolastine in healthy volunteers with an indirect response model

1 reference

12 December 2020

Characteristics of indirect pharmacodynamic models and applications to clinical drug responses

1 reference

12 December 2020

Preclinical pharmacology of bilastine, a new selective histamine H1 receptor antagonist: receptor selectivity and in vitro antihistaminic activity

1 reference

12 December 2020

A randomized, double-blind, crossover comparison among cetirizine, levocetirizine, and ucb 28557 on histamine-induced cutaneous responses in healthy adult volunteers

1 reference

12 December 2020

Comparison of four basic models of indirect pharmacodynamic responses

1 reference

12 December 2020

A double-blind, single-dose, crossover comparison of cetirizine, terfenadine, loratadine, astemizole, and chlorpheniramine versus placebo: suppressive effects on histamine-induced wheals and flares during 24 hours in normal subjects

1 reference

12 December 2020

The effect of H1 and H2 blockade on cutaneous histamine response in man.

1 reference

12 December 2020

Lack of subsensitivity to mizolastine over 8-week treatment

1 reference

12 December 2020

Inhibition of the histamine-induced weal and flare response: a valid surrogate measure for antihistamine clinical efficacy?

1 reference

12 December 2020

In vivo pharmacological characterisation of bilastine, a potent and selective histamine H1 receptor antagonist

1 reference

12 December 2020

10.2165/11317180-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

5 August 2017

1012813271

0 references

1 reference